Chemours Quarterly Balance Sheet
NYSE: CCIndustrialsMajor ChemicalsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Chemours financial position
As of Jun 30, 2026, Chemours reported total assets of $7.15 billion, down 4.2% from a year earlier against total liabilities of $7.20 billion. Shareholders' equity was negative at -$49.0 million, meaning liabilities exceed assets; this is often the result of large share buybacks or accumulated losses. The company held $671.0 million in cash and equivalents against $3.87 billion of debt, a net debt position of $3.20 billion.
The current ratio (current assets divided by current liabilities) was 1.66, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Chemours balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 671.00M | 563.00M | 670.00M | 613.00M | 502.00M | 464.00M | 713.00M | 596.00M | 604.00M | 746.00M | 1.20B | 852.00M |
| Receivables | 773.00M | 645.00M | 562.00M | 817.00M | 813.00M | 704.00M | 619.00M | 825.00M | 788.00M | 692.00M | 509.00M | 753.00M |
| Inventory | 1.45B | 1.54B | 1.57B | 1.55B | 1.56B | 1.55B | 1.46B | 1.43B | 1.36B | 1.38B | 1.35B | 1.31B |
| Total Current Assets | 3.09B | 2.93B | 3.00B | 3.21B | 3.10B | 2.93B | 3.02B | 3.08B | 2.94B | 3.61B | 3.84B | 3.68B |
| Property, Plant & Equipment | 3.03B | 3.04B | 3.08B | 3.10B | 3.13B | 3.14B | 3.19B | 3.17B | 3.15B | 3.20B | 3.21B | 3.12B |
| Goodwill | 46.00M | 46.00M | 46.00M | 46.00M | 46.00M | 46.00M | 46.00M | 46.00M | 102.00M | 102.00M | 102.00M | 102.00M |
| Intangible Assets | — | — | 2.00M | 2.00M | — | — | 3.00M | 3.00M | — | — | 3.00M | — |
| Total Assets | 7.15B | 7.27B | 7.38B | 7.55B | 7.46B | 7.38B | 7.51B | 7.46B | 7.25B | 7.98B | 8.24B | 7.95B |
| Accounts Payable | 937.00M | 891.00M | 954.00M | 1.03B | 1.02B | 1.01B | 1.16B | 1.08B | 941.00M | 964.00M | 1.16B | 885.00M |
| Short-Term Debt | 34.00M | 37.00M | 42.00M | 52.00M | 38.00M | 43.00M | 54.00M | 53.00M | 37.00M | 41.00M | 51.00M | 39.00M |
| Total Current Liabilities | 1.86B | 1.61B | 1.69B | 1.87B | 1.83B | 1.67B | 1.82B | 1.79B | 1.56B | 2.23B | 2.49B | 2.92B |
| Long-Term Debt | 3.84B | 4.10B | 4.10B | 4.10B | 4.11B | 4.07B | 4.06B | 3.99B | 3.95B | 3.97B | 3.99B | 3.94B |
| Total Liabilities | 7.20B | 7.05B | 7.13B | 7.27B | 7.23B | 6.81B | 6.94B | 6.81B | 6.53B | 7.23B | 7.52B | 7.20B |
| Shareholders' Equity | -49.00M | 215.00M | 250.00M | 274.00M | 228.00M | 566.00M | 571.00M | 643.00M | 714.00M | 753.00M | 721.00M | 755.00M |
| Retained Earnings | 891.00M | 1.18B | 1.22B | 1.28B | 1.25B | 1.64B | 1.69B | 1.75B | 1.82B | 1.80B | 1.78B | 1.84B |
| Total Debt | 3.87B | 4.14B | 4.14B | 4.16B | 4.15B | 4.11B | 4.11B | 4.04B | 3.99B | 4.01B | 4.04B | 3.98B |
| Net Cash (Debt) | -3.20B | -3.57B | -3.47B | -3.54B | -3.64B | -3.65B | -3.40B | -3.44B | -3.39B | -3.27B | -2.84B | -3.13B |
| Shares Outstanding | 150.46M | 150.36M | 149.89M | 149.87M | 149.70M | 149.57M | 149.43M | 149.39M | 149.25M | 148.78M | 148.59M | 148.36M |
This table shows 12 quarterly periods of Chemours's balance sheet, from Q2 2026 back to Q3 2023, across 18 line items including cash & equivalents, receivables, inventory. Values in USD; B = billions, M = millions. Fiscal periods follow CC's reporting calendar. What is a balance sheet?